Friday 22 November 2019

Microfluidic Devices Market Profile | Growth and SWOT Analysis | Forecast To 2025

Microfluidic Devices Market Size And Growth Analysis By Material (Polymer, Glass, Silicon And Others), Industry (In-Vitro Diagnostics, Pharmaceutical (Chips For Lab Analytics, Accurate Dispensing Devices And Micro-Reactors For Drug Synthesis), Medical Devices (Micro Pumps And Dispensing System, Inhalers, Micro-Needles And Others) And Others))), Application (Pharmaceutical And Life Science Research, Clinical And Veterinary Diagnostics, Point Of Care Diagnostics, Analytical Devices, Drug Delivery, Environmental And Industrial And Others), Key Players And Region Forecast To 2025

Microfluidic Devices market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2025

The Global microfluidic devices market size is predicted to touch USD 14,296.04 Million at a 19.70% CAGR over the forecast period (2019-2025), as per the latest Market Research Future (MRFR) report. Microfluidic device, simply put, is a technology which enables the integration of several medical tests on one chip. This has turned into a crucial technology for parallelization, miniaturization, industrialization, and integration of numerous tests in diagnostics, biological research, and drug development.

Various factors are propelling the microfluidic devices market growth. These factors, according to the latest MRFR report, include the rise in demand for point of care testing products, growing demand in proteomics and genomics, miniaturization of chips, liquid biopsies, personalized medicine, and organ-on-a-chip. Additional factors pushing market growth include rising use in drug delivery systems, especially inhalers and insulin pumps and growing awareness of the benefits of microfluidic devices.

On the contrary, stringent government policies may hamper the microfluidic devices market growth over the forecast period.

Microfluidic Devices Market Segmentation

The Market Research Future report provides a wide segmental analysis of the microfluidic devices market based on industry, material, and application.

Based on industry, the microfluidic devices market is segmented into medical devices, pharmaceutical, in-vitro diagnostics, and others. The pharmaceutical segment is further segmented into micro-reactors for drug synthesis, accurate dispensing devices, and lab analytics. The medical devices segment is again segmented into micro-needles, inhalers, dispensing system, micro-pumps, and others. Of these, the in-vitro diagnostics segment will have the largest share in the market over the forecast period. This is owing to the growing demand for early diagnosis.
Based on material, the microfluidic devices market is segmented into silicon, glass, polymer, and others. Of these, the polymer segment will dominate the market over the forecast period. Polymer is an affordable material that allows for rapid fabrication processes compared to glass and silicon. Polydimethylsiloxane (PDMS), polycarbonate, cyclic olefin copolymer, polymethyl methacrylate, polyvinyl chloride, and polystyrene are the most common polymers used in prototyping microfluidic devices fabrication of microfluidic chips.

By application, the microfluidic devices market is segmented into environmental and industrial, drug delivery, analytical devices, point of care diagnosis, clinical and veterinary diagnostics, and pharmaceutical and life science research.

Microfluidic Devices Regional Analysis
Based on the region, report covers the latest microfluidic devices market trends and growth opportunities across Europe, the Americas, Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will lead the market over the forecast period. This is due to the rising geriatric population, rising healthcare awareness, increasing lifestyle and chronic diseases, technological developments for different home use applications, and extensive insurance infrastructure facilities.

The microfluidic devices market in Europe is predicted to have the second-largest share in the market over the forecast period. This is owing to the increasing participation of market players and technological advancements
The microfluidic devices market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to the introduction of technologically advanced products by leading companies.
The microfluidic devices market in the Middle East and Africa will have a minimal share in the market during the forecast period due to the low economic development in the African region.

Microfluidic Devices Key Players
Leading players profiled in the microfluidic devices market report include BioMérieux, Thermo Fisher Scientific Inc., Perkinelmer Inc., Elveflow, BD, Johnson & Johnson Services, Inc., Micronit Microtechnologies, Dolomite Microfluidics, RainDance Technologies, Inc., CEPHEID, BIO-RAD LABORATORIES, INC., Fluidigm, Siemens, Agilent Technologies, Inc., F. HOFFMANN-LA ROCHE AG, and Abbott Laboratories.  

Various strategies acquired by the key players in the market to create a niche in the market, such as expansion, acquisition, product development, and innovation.

Researchers at the Singapore University of Technology and Design’s Soft Fluidics Lab have developed a low cost, rapid technique to 3D print microfluidic devices. This method will enable fabrication of microfluidic channels, which are tunable dynamically in dimensions. The researchers have applied DIW (direct ink writing) 3D printing of the fast-curing silicone sealant for fabricating microfluidic devices on various substrates such as membranes, plastic, and glass.

Brows More Healthcare Related Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com.
at No comments:

Genitourinary Drugs Market Segmentation | Sales, Cost and Capacity | Forecast To 2023

Market Highlights
Genitourinary Drugs market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2025

Global Genitourinary Drugs Market Size and share to project lucrative CAGR by 2023, says Market Research Future (MRFR). Genitourinary drugs are used for the treatment of medical complications related to the kidney, bladder, ureter and urethra. Genitourinary disorders are caused by damage to the urinary tract or genital organs. The increasing cases of genitourinary disorders, surge in number of people suffering from cancer, increasing prevalence of sexually transmitted diseases, and rise in number of drugs in pipeline are the major factors driving the growth of the global genitourinary drugs market.

According to the Centers for Disease Control and Prevention (CDC), more than 2.3 million Americans were diagnosed with sexually transmitted diseases in year 2017, Most common sexually transmitted diseases in American region are chlamydia, gonorrhea, and syphilis. Moreover, increase in strategic collaborations and aggressive strategy adopted by major players in the market is also responsible for the growth of the market.
The increasing appearance of drug counterfeiting in pharmaceutical industry, intense competition from generic manufacturers and drug patent expirations are likely to hinder market growth during the forecast period.

Genitourinary Drugs Market Segmentation:
The global genitourinary drugs market has been segmented based on disease, product, and end-user.
The market, by disease, has been classified as urinary tract infections, erectile dysfunction, urinary incontinence & overactive bladder, kidney/renal cancer, genitourinary cancer, bladder cancer, bladder cancer, cervical cancer, sexually transmitted diseases, interstitial cystitis, hematuria, ovarian cancer, and prostate cancer.
On the basis of product, the market has been segregated into urologicals, hormonal therapy, gynecologicals, and anti-infectives.

The end-user segment has been divided into, hospitals, clinics, super specialty centers, and others.

Genitourinary Drugs Market Key Players:
Some of the key players in the global genitourinary drugs market are Bayer AG, Astra Zeneca, Abbott, Astellas Pharma Inc., Pfizer Inc., Eli Lilly and Company, Genentech, Inc., Immunex Corp. GlaxoSmithKline plc., Ionis Pharmaceuticals, Inc., Merck & Co., Bristol-Myers Squibb Company, Antares Pharma, and Novartis AG

Genitourinary Drugs Market Regional Analysis:
The market in the Americas is expected to dominate the global genitourinary drugs market share during the forecast period owing to the rising prevalence of genitourinary disorders, increasing cancer patients in the region, rise in healthcare expenditure, and the presence of a well-established healthcare system. The European market is expected to be the second-largest due to the government initiatives for the development of healthcare sector, increasing research and development activities in the region and rise in number of chronic disorders.
Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing geriatric population, rising investments in healthcare sector and favorable government policies. The market in the Middle East & Africa is likely to account for the smallest share of the global genitourinary drugs market. The market growth in this region can be attributed to increasing healthcare expenditure and growing medical tourism.

Brows More Related Research Reports

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com.

at No comments:

Leukapheresis Market Segmentation | Dynamics and Share | Forecast To 2023

Leukapheresis Market Highlights:
Leukapheresis market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2023

Leukapheresis Market size was valued USD 19.2 million in 2017 and is projected to grow at a CAGR of 7.7% over the forecast period. Leukapheresis is a laboratory procedure in which white blood cells (WBCs) are separated from a sample of blood. Leukapheresis is majorly carried out for chronic lymphocytic leukemia.

The factors such as increasing number of blood donations, rising prevalence of leukemia, and demand for leukapheresis products in clinical research are anticipated to propel the growth of the market over the forecast period. According to the National Institutes of Health (NIH) estimates, the number of new cases of leukemia has increased on an average rate of 0.3% each year over the period from 2006-2015. It also stated that the number of new cases may reach 60,300 in the year 2018. Despite the drivers, the high cost of therapeutic leukapheresis, dearth of skilled professionals, and stringent donor recruitment criteria may hamper the market growth over the assessment period.

Currently, many companies are operating in the global leukapheresis products market. The prominent players in the market are engaged in strategic collaborations, acquisitions, regional expansion, and new product launches to strengthen their market position. For instance, in February 2018, Terumo BCT entered into collaboration with Stafa Cellular Therapy. With this collaboration, Terumo BCT will act as a distributor for Stafa Cellular Therapy and will expand its access to StafaCT software to healthcare organizations.

Leukapheresis Market Key Players:
Some of the prominent players in the global leukapheresis products market are Haemonetics, Terumo BCT, Asahi Kasei Medical, STEMCELL Technologies, Macopharma, HemaCare Corporation, Caltag Medsystem, ALLCells, LLC, ZENBIO, Fresenius Kabi, PPA Research Group, and StemExpress

Leukapheresis Market Segmentation:
The global leukapheresis products market has been segmented into type, application, and end user. Based on type, the market has been segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment has been segmented into apheresis devices, leukapheresis column & cell separators, and leukoreduction filters.

The market, by application, has been segmented into research applications and therapeutic applications.
Based on end user, the market has been segmented into blood component providers and blood centers, hospitals and transfusion centers, and others.

Leukapheresis Market Regional Analysis:
Geographically, the Americas is anticipated to dominate the global leukapheresis market share owing to the rising number of blood donations, and growing incidence and prevalence of leukemia. Europe is anticipated to hold the second largest position in the global leukapheresis products market. The market growth in this region is mainly due to the rising prevalence of leukemia and presence of well-developed healthcare sector in the region.
Asia-Pacific region is expected to be fastest growing region due to the increase in regenerative medicine research in the region, growth in the number of clinical trials for CAR-T therapy, and the increasing presence of major pharma and biotech companies. The Middle East & Africa has the least share of the global leukapheresis products market owing the poor healthcare infrastructure especially in the Africa region.

Brows More Healthcare Related Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Mastitis Market SWOT Analysis By Revenue, Price & Growth Rate | Forecast To 2023

Market Overview:
Mastitis market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2023

The Global Mastitis Market Size was valued USD 7,898.05 Million and projected to reach USD 18,338 Million at a CAGR of 15.07% during the forecast period (2017-2023) says Market Research Future (MRFR). The North America mastitis market is expected to reach USD 7,054.58 Million followed by European mastitis market to reach USD 5,275.18 million and APAC mastitis market will reach the valuation of USD 5,000.41 million by 2023.
Mastitis refers to a kind of infection occurring in the tissues of mammary glands in the breast. The mastitis usually affects women who are breastfeeding as a result of a blocked duct. In cows, mastitis occurs as a result of chemical, mechanical, or thermal injury to the cow’s udder.

Affected bovine and human population are driving the growth of the global mastitis market. With the various technological advancements in recent years, the global mastitis market has been witnessing many innovations in treatment methods and drugs to treat the infection.

Furthermore, factors such as the growing prevalence of breast cancer is impacting the market growth positively.  Women affected with breast cancer are at high-risk of contracting mastitis during the breastfeeding period. Hence, the rise in the breast cancer cases across the globe accounts for the key risk factor increasing the incidents of the mastitis.

Rapid changes in lifestyle, eating habits, and changes in the social system over the last few years have been accelerating the market growth. According to the World Cancer Research Fund, breast cancer is the most common cancer in women worldwide and the second most common cancer. The World Cancer Research Fund has also reported over 2 million new cases of breast cancer in 2018.

However, lack of awareness towards the mastitis conditions, low awareness levels regarding bovine health, and the lack of awareness of losses caused by bovine mastitis are some of the factors hampering the market growth. Consequences in incorrect diagnosis due to similarities in the symptoms of breast cancer and mastitis can hamper the market growth.

Mastitis Market Segmentation:
The global mastitis market can be segmented by type, treatment, end-user, and region.
By type, the global mastitis market is segmented into human mastitis and bovine mastitis. The segment bovine mastitis accounted for the major share in the global mastitis market in 2017. Whereas the subsegment contagious mastitis had valued at USD 3,843.23 MN in 2017 and is expected to exhibit a CAGR of 16.91 % during the forecast period (2017-2023). Environmental mastitis accounted for a 38 % of the share of bovine mastitis, in 2017.
By treatment, the mastitis market is segmented into antibiotics, pain relievers, surgery, vaccines, and others. Antibiotics by bovine treatment accounted for the valuation of USD 6,448.56 million in 2017. The antibiotics subsegment is further expected to register a CAGR of 16.56% throughout the forecast period.

Based on end-user, the mastitis market is segmented into hospitals, clinics, veterinary centers, and others. In 2018, the hospitals and clinics segment is expected to account for the largest share of the global mastitis market. Veterinary centers accounted for the largest share of the market in 2017.

The subsegment Veterinary centers by the end-user accounted for the valuation of approximately USD 6,326.34 million in 2017 and is projected to register a CAGR of 16.87% over the forecast period.

Mastitis Market Competitive Dashboard:
Prominent players operating in the mastitis market include Bayer AG (Germany), Pfizer Inc. (U.S.), BioNumerik Pharmaceuticals Inc. (U.S.), Zoetis Inc. (U.S.), Sanofi S.A. (France), Merck Co & Inc. (U.S.), Oncothyreon Inc. (U.S.), Oncogenex (U.S.), Apthera Inc. (U.K.), Astellas Pharma Inc. (Japan), Novartis AG (Switzerland), Boehringer Ingelheim GmbH (Germany), F. Hoffmann-La Roche Ltd. (Switzerland).
Strategic initiatives employed often involve mergers, acquisitions, product launches, and others. These tactical moves ensure individual growth of companies alongside the market’s expansion.

Mastitis Market Regional Analysis:
The Americas region dominates the global mastitis market share mainly due to the higher health care expenditures and the increasing prevalence of mastitis among the bovine population. The US backed by the growing prevalence of human mastitis, and bovine’s mastitis accounts for the major growth supporter to the regional market.
Europe mastitis market stands the second position, globally mainly due to the high prevalence of breast cancer. Moreover, factors such as the accessibility to advanced treatment facilities, rising government initiatives to promote healthy breastfeeding, and growing healthcare expenditures are fostering the growth of the regional market.
The mastitis market in the Asia Pacific region is expected to emerge as a promising market, growing rapidly due to the government initiatives of healthcare reforms. Increasing demand for advanced treatment therapies mainly in emerging economies such as China and India are leading the growth in the mastitis market in the region.

Brows More Healthcare Related Research Reports at:

About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
at No comments:

Lice Treatment Market Insights | Emerging Trends & Demand | Forecast To 2023

Lice Treatment Market Highlights:
Lice Treatment market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2023

The Global Lice Treatment Market Size is expected to grow at an approximate CAGR of 6.5% during forecast period, 2018–2023. Lice are parasites striving on human blood. They can be found on head or pubic areas. From the past few years, rising prevalence of head lice provided developmental backgrounds for the market. Factors such as growing children population and increasing disposable income are driving the market. However, lack of awareness followed by low per capita healthcare expenditure in the developing and low-income countries is estimated to restraint the market growth, during the forecast period.

Lice Treatment Market Segmentation:
The Global Lice Treatment Market is segmented based on type, treatment, end user, and region Based on type, the market is segmented into pediculosis capitis, pediculosis corporis, and pediculosis pubis. Based on treatment, the market is divided into two, i.e., OTC (over the counter) products and prescription medications. The OTC medication segment is bifurcated into permethrin, pyrethrin, and others.  The prescription segment is sub-segmented into ivermectin, spinosad, malathion, and others. By distribution channel, the market is segmented into hospitals & clinics, retail pharmacies, and online platform. On the basis of region, the market is segmented into the Americas, Europe, Asia Pacific and the Middle East & Africa.

Lice Treatment Market Regional Analysis:
The Americas leads the global lice treatment market share. This can be attributed due to growing child population and presence of major market players within the region. Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth. In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of a well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure. Asia Pacific was estimated to be the fastest growing region in 2017. This can be attributed due to the high contamination rate, increasing household income and growing penetration of the market players within the region. Moreover, rapidly growing pharmaceutical sector within the region boosts the market to grow.

On the other hand, the Middle East and Africa held the least share in the global lice treatment market. This can be attributed due to the presence of poor economies, stringent government policies and low per capita income, especially within the African region. A majority of the of the market share within the Middle East & Africa is estimated to be held by the Middle East due to increasing government funding for healthcare, improving healthcare facilities and presence of developed economies like United Arab Emirates, Saudi Arabia, Kuwait, Dubai, and others.

Lice Treatment Market Key Players:
Some of the key players in the global lice treatment market are AkzoNobel N.V., Alliance Pharmaceuticals Ltd., Bayer HealthCare, Dow AgroSciences LLC, Elanco, GlaxoSmithKline, Insight Pharmaceuticals, Johnson & Johnson, Omega Pharma, Pfizer, Sanofi, Suven Life Sciences, Taro Pharmaceuticals, Topaz Pharmaceuticals Inc., and others

Brows More Healthcare Related Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

Lip Augmentation Market Share, Size, Growth and Dynamics | Forecast To 2023

Lip Augmentation Market
lip augmentation market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2023
The global lip augmentation market size is expected to grow at an approximate CAGR of 10.5% during forecast period, 2018–2023.

Rising participation of market players is one of the prominent factors driving the lip augmentation market. For instance, in 2018, Allergan plc launched a new JUVÉDERM advertising campaign created to empower the next generation of consumers to “JUVÉDERM IT.” The JUVÉDERM collection of fillers offers a complete range of dermal fillers for different patient needs. JUVÉDERM Ultra XC is used into the lips and perioral area for lip augmentation in adults over 21.

Various other factors such as increasing awareness about lip augmentation, rising geriatric population and rising demand for dermal fillers are also expected to propel the growth of the market.
However, side effects associated with lip fillers and high cost of treatment can hamper the market growth over the forecast period.

Lip Augmentation Market Segmentation
The global lip augmentation market is segmented based on type, lip fillers, distribution channel, and region.
The global market for lip augmentation, by type is segmented into temporary lip augmentation and permanent lip augmentation. The permanent lip augmentation segment is further classified as dermal graft, permanent lip implants, vermilion lip advancement and lip lift. The lip lift segment includes corner lip lift and upper lip lift.
The market, by lip fillers, is segmented into fat injection or lipoinjection, hyaluronic acid fillers, lip collagen injections, platelet-rich plasma (PRP), and others.

Based on distribution channel, the market is segmented into hospital pharmacies, clinics, retail pharmacies, drug stores, online pharmacies, and others.

The hospital pharmacies segment is anticipated to hold the largest market share owing to the increasing demand for cosmetic procedures. The online pharmacies are expected to grow at the highest CAGR owing to the rising cases of cosmetic problems.

Lip Augmentation Market Regional Analysis
The Americas dominated the global lip augmentation market share owing to the rising geriatric population. According to the Population Reference Bureau report, the number of Americans ages 65 and older is projected to double from 46 million today to over 98 million by 2060. Moreover, rising healthcare spending within the region is also boosting the lip augmentation market. In the US, the total healthcare spending reached USD 3.5 trillion in 2017 and by 2026; it is expected to reach USD 5.7 trillion.

In 2017, it was estimated that Europe stood second in the global lip augmentation market. This can be attributed to the rising research and development investments and technological advancements. For instance, in 2017, Allergan received FDA approval for its newest hyaluronic acid dermal filler, Juvéderm Vollure XC.
Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing medical tourism industry and increasing technological advancements within the region are boosting the regional markets of the Asia Pacific region.

On the other hand, the Middle East and Africa held least share in the global lip augmentation market due to the low per capita income, especially within the African region.

Lip Augmentation Market Key Players
Some of the key players in the global lip augmentation market are Allergan, Galderma Pharma S.A., Integra Lifesciences, Laboratories Vivacy SAS, Merz Pharma, Sinclair Pharma, Suneva Medical, Inc, Teoxane, Cynosure, Syneron, AQTIS Medical, Bioha Laboratories, Cytophil, Inc., Dr. Korman Laboratories, Inamed Corporation, and Anika Therapeutics Inc., and others.

Brows More Healthcare Related Research Reports at:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
at No comments:

CBD Market Profile, Segmentation, Vendor Landscape | Forecast To 2026

CBD (Cannabidiol) Market Size, Growth and Analysis by Form (Solid and Liquid), Route of Administration (Tincture, Capsules, Inhalation (Smoke or Vapor) , Aerosol Spray), Product (Food Grade and Therapeutic Grade), Application (Neurogenerative Disorder, Fibromyalgia, Diabetes , Protein Bars , Energy Drinks), End User (Food & Beverage, Healthcare), Source (Organic Inorganic) and Region (North America, Europe, Asia Pacific, ROW) - Global Forecast till 2026

Cannabidiol (CBD) is a non-addictive compound found in the cannabis plant. Its properties of anti-inflammation, anti-anxiety, analgesic, and seizure-suppression are likely to induce heavy demand for the compound in food & beverage and personal skincare sectors. The report written by reputed analysts at Market Research asserts global CBD Industry growth trajectory for period between 2019 and 2026.

Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/8090

CBD Market Overview
The global CBD market size is poised to reach USD 22,07,162.54 million by 2026. It can achieve this mark by exhibiting a CAGR of 125.58% from 2019 to 2026 (forecast period). The use of CBD by patients for alleviating pain levels to a considerable degree is likely to drive the market demand till 2026. According to the National Center for Biotechnology, close to 62% of the global population used CBD for treating medical conditions between 2017 and 2018.

CBD Market Segmentation
The global CBD market analysis is majorly bifurcated based on its form, route of administration, production, inhalation, application, and end-user.

The form segment is divided into liquid and solid.
Based on the product, the global CBD market is classified into therapeutic grade and food grade.
Further, the application segment is bifurcated into protein bars, neurogenerative disorder, diabetes, fibromyalgia, and energy drinks.

The global CBD market is segmented into healthcare, personal care, and food & beverage; based on end-user industry.

Based on route of administration, the global CBD market is bifurcated into tincture inhalation, aerosol, and capsules. The inhalation segment is further divided into vapor and smoke.

CBD Industry Players
The key players functioning with their product offering maintaining the momentum of the global CBD market are CV Sciences, Elixinol Global Limited, Green Roads of Florida, Folium Biosciences, Elixinol Global Limited, Medical Marijuana, Inc., Canopy Growth Corporation, CBD Health Solutions, ENDOCA, and Freedom Leaf.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +16468459312
Email: sales@marketresearchfuture.com

at No comments:
Subscribe to: Posts (Atom)

Ultra-low Temperature Freezers Market Profile, Trends and Applications By 2027

  According to the MRFR reports, the global   ultra-low temperature freezers market   is projected to acquire a market size of approximately...